Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.

First author:Tao Wang

Corresponding author:Yong Zhang

Lower Urinary Tract Dysfunction; Multiple Sclerosi

essential_information

  • Person in charge:Tao Wang
  • Data Sources: OTHERS
  • Number of papers:OTHERS20190460
  • Published time:2016-03-20

2016-03-20

Published articles

Journal:Chinese Medical Journal

Publication type: Research Article

IF(IF): 2.628

PMID: 26960366 Link To Pubmed Full text Download

Background And Purpose

Method

We enrolled 126 patients with urological dysfunction who were recruited between July 2008 and January 2015 in Beijing Tian Tan Hospital, Capital Medical University and conducted overactive bladder system score (OABSS), urodynamic investigation, and expanded disability status scale (EDSS). Changes of urinary symptoms and urodynamic parameters were investigated.

Conclusion

Urodynamic parameters examined are important in providing an accurate diagnosis, guiding management decisions of MS. Early and effective treatment may improve the bladder function and the quality of life at the early stages of MS.

Main results

Urgency was the predominant urinary symptom, and detrusor overactivity was the major bladder dysfunction. There was a positive correlation between EDSS and OABSS. Clinically isolated syndrome (CIS) had lowest EDSS and OABSS. CIS exhibited significant improvements in OABSS, maximum urinary flow rate (Qmax), and bladder volume at the first desire to voiding and maximum bladder volume after the treatment (P < 0.05). Relapsing-remitting MS showed significant improvements in the OABSS, Qmax, and bladder volume at the first desire to voiding, maximum bladder volume and bladder compliance after the treatment (P < 0.05). Progressive MS exhibited significant increase in the bladder volume at the first desire to voiding, the detrusor pressure at maximum flow rate (PdetQmax), and bladder compliance after the treatment (P < 0.05).